TMSB4X and neoplasm: In the correlation analysis of clinicopathological features, the patients with high IHC expression of TMSB4X were found significantly associated with tumor recurrence (P = 0.017) (see Table 2), and also presented poor overall survival rate (OS, P = 0.006, Fig. 4B) as well as recurrence-free survival rate (RFS, P = 0.013, Fig. 4C).